History is being made. An innovative type of HIV vaccine procedure is being tested in a study called HVTN 702. The target is to enroll 5,400 men and women to determine if the vaccine can safely prevent HIV infection. Safety will be carefully supervised.

HIV vaccine clinical study

The study seeks to enroll uninfected, sexually active men and women aged 18 to 35 years, at 15 sites across South Africa, with the outcome due in 4 years. The study design comprises that participants are randomly assigned to either the investigational vaccine group or a placebo.

(A placebo is an inactive substance). All study participants will receive a total of five injections over one year.

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health and a co-funder of the trial, “If deployed alongside our current armory of proven HIV prevention tools, a safe and effective vaccine could be the final nail in the coffin for HIV. Even a moderately effective vaccine would significantly decrease the burden of HIV disease over time in countries and populations with high rates of HIV infection, such as South Africa.”

Human immunodeficiency virus

HIV is the name given when a patient tests positive for HIV antibodies.

The goal of HIV treatment is to suppress the virus or viral load as low as possible for as long as possible. HIV testing is simple and involves an oral swab results within twenty minutes. It is available over the counter and at clinics that can personalize HIV prevention education with a focus on risk reduction.

New infections

This will be the biggest and most sophisticated advanced clinical trial to be conducted.

In South Africa, more than 1,000 people become infected with HIV daily. In the Unites States, about 108 people are infected daily. Additionally, in excess of 1.2 million U. S. people are living with HIV, and 1 in 8 of them does not know it.

  • Lack of access to information and education
  • Lack of access to medical care
  • Mental and emotional realities
  • Physiological realities
  • Information alone does not change behavior

HIV Prevention

  • Education
  • Outreach
  • Vaccine
  • Drug regimen
  • Testing


The National Institutes of Health (NIH), overseeing the HIV vaccine study, is a medical research agency, includes 27 Institutes and Centers and is a component of the U.S.

Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.

Don't miss our page on Facebook!